Common Cold

Common Cold

1 Overview

Summary and Quick Facts

  • It has been estimated that the U.S. population contracts approximately 1 billion colds per year. The common cold is a leading cause of medical visits and missed days at work or school.
  • Treatment strategies for the common cold are generally aimed at relieving symptoms, shortening duration and minimizing the risk of complications.
  • Several innovative and integrative strategies such as vitamin D, garlic, zinc, astragalus, beta glucan and probiotics have been shown in scientific studies to help manage symptom duration and intensity associated with the common cold.

What is the Common Cold?

The common cold is a viral infection of the upper respiratory tract. Common colds may be caused by over 200 distinct viral pathogens, the most common being rhinovirus, coronavirus, and respiratory syncytial virus. Because there are so many distinct cold-causing viruses, developing immunity against the common cold is unlikely.

Infection occurs when the virus comes in contact with mucous membranes (eg, eyes, nose, mouth). Colds generally resolve without treatment, and conventional treatments are mostly palliative and aim to shorten the duration of the illness. An over-the-counter stomach acid medication, cimetidine, may augment the body’s immune response to viral pathogens and prevent colds from setting in.

Natural interventions such as vitamin D and zinc may help prevent the common cold and aid the body’s immune response.

What are Signs and Symptoms of the Common Cold?

  • Runny/stuffy nose
  • Sore throat
  • Coughing and sneezing
  • Low-grade fever
  • Mild aches

Note: Cold symptoms are usually mild and resolve within 7–10 days. If symptoms are more severe (eg, high fever, severe body aches), notify a healthcare provider as this may indicate a more serious condition, such as the flu.

What are Ways to Prevent the Common Cold?

  • Avoid contact with others while you have cold symptoms.
  • Direct coughs or sneezes into the crook of your elbow, not your hand or the air.
  • Avoid touching your eyes, nose, and mouth during cold outbreaks.
  • Wash and sanitize hands and surfaces.
  • Exercise regularly.
  • Get adequate sleep (quality and quantity).
  • Take extra around children, as they are more prone to colds. Be vigilant about hand hygiene and disinfecting surfaces.

What are Conventional Medical Treatments for the Common Cold?

  • DO NOT take antibiotics for a common cold. Antibiotics will not work against the common cold and can contribute to the development of drug resistant pathogens. Antibiotics are reserved for bacterial infections, such as secondary bacterial sinusitis.
  • Over-the-counter medications that may help relieve some cold symptoms include:
    • Oxymetazoline and pseudoephedrine for stuffy nose
    • Diphenhydramine for runny nose, sneezing, and coughing
    • Dextromethorphan for coughing
    • Mild analgesics such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs)

Note: Many cold medicines contain the same active ingredients. ALWAYS read labels to ensure you do not exceed the recommended dose.

What Natural Interventions May Be Beneficial for the Common Cold?

  • Vitamin D. Vitamin D has a significant role in regulating the immune system. Daily or weekly supplementation and higher vitamin D levels are associated with a decreased risk of seasonal viral infection and acute respiratory infection.
  • Vitamin C. Vitamin C augments several aspects of the immune system and helps defend against infections. Using vitamin C may reduce the chances of catching a cold and cold duration.
  • Zinc. Zinc deficiency has been linked to immune impairment and susceptibility to infection; supplementation can bolster the body’s ability to fight off viruses. Using zinc within 24 hours of symptom onset may reduce the duration and severity of a cold.
  • Dehydroepiandrosterone (DHEA). DHEA has powerful immune-enhancing and antiviral properties and can increase resistance to many experimental infections. Supplementation in elderly populations is likely to be important, as DHEA declines with age.
  • Melatonin. Melatonin helps combat many types of viral infections. Its administration is associated with increased production of antibodies and like DHEA, may be especially helpful in elderly populations.
  • Elderberry. Elderberry has been used for its medicinal properties since ancient times. Elderberry extracts are used for managing viral infections, such as the common cold.
  • Garlic. Allicin, a compound found in garlic, has demonstrated antiviral activity. Allicin-containing garlic supplements may help prevent viral infection and reduce duration of cold symptoms.
  • Andrographis paniculata. Andrographis paniculata has been used for centuries among Asian cultures to treat colds. Standardized extracts can reduce symptoms of upper respiratory tract infection and may prevent colds as well.
  • Probiotics. Probiotics may help prevent infection and reduce the risk of catching a common cold. Some probiotics are also associated with reduced severity and duration of symptoms caused by common upper respiratory tract infections.
  • Other natural interventions that may be beneficial for common colds include Astragalus membranaceus, lactoferrin, beta-glucan, echinacea, honey, and enzymatically modified rice bran.

2 Introduction

Preamble

If you are reading this because you have developed cold symptoms, it is critical that you act quickly to halt the rapid replication of viruses occurring in your body at this very moment. Go to the nearest health food store or pharmacy and purchase:

  1. Zinc Lozenges: Completely dissolve in mouth one lozenge containing 18.75 mg of zinc acetate every two waking hours. Do not exceed 8 lozenges daily, and do not use for more than three consecutive days.
  2. Garlic: Take 9000-18,000 mg of a high-allicin garlic supplement each day until symptoms subside. Take with food to minimize stomach irritation.
  3. Vitamin D: If you don't already maintain a blood level of 25-hydroxyvitamin D over 50 ng/mL, then take 50,000 IU of vitamin D the first day and continue for three more days and slowly reduce the dose to around 5000 IU of vitamin D each day. If you already take around 5000 IU of vitamin D every day, then you probably don't need to increase your intake.
  4. Cimetidine: Take 800-1200 mg a day in divided doses. Cimetidine is a heartburn drug that has potent immune enhancing properties. (It is sold in pharmacies over-the-counter.)
  5. Melatonin: 3 to 50 mg at bedtime.

Do not delay implementing the above regimen. Once the cold virus infects too many cells, it replicates out of control and strategies like zinc lozenges will not be effective. Treatment must be initiated as soon as symptoms manifest! 

Introduction

The common cold is a viral infection of the upper respiratory tract that causes symptoms such as a runny or stuffy nose, sneezing, coughing, and sore throat (Turner 2009; Turner 2011; Mayo Clinc 2011). Systemic symptoms such as mild headache, fatigue, fever, and muscle aches can occasionally occur with the common cold as well. However, if these symptoms are severe and/or accompanied by fever or significant exhaustion, they likely indicate the "flu", which is a distinct type of viral respiratory infection caused by an influenza virus (CDC 2011; Hayden 2011; NIAID 2011a).

It has been estimated that the U.S. population contracts approximately 1 billion colds per year, and the common cold is a leading cause of medical visits and missed days at work or school (Singh 2011; Roxas 2007). Although most cases of the common cold are mild and self-limiting, the illness represents a major economic burden to society in terms of lost productivity and treatment expenditure (Maggini 2012; Lissiman 2012; Turner 2009).

Treatment strategies for the common cold are generally aimed at relieving symptoms, shortening duration, and minimizing the risk of complications (Roxas 2007; Albalawi 2011).

Conventional cold treatments include over-the-counter analgesics and decongestant medications (Roxas 2007; NIH 2012b). However, these strategies are minimally effective (Nahas 2011), and even when used appropriately, may be associated with significant side effects (Shefrin 2009).

A number of specific antiviral drugs have some degree of effectiveness against common cold viruses. One exciting candidate is Biota's vapendavir, which recently met key milestones for benefit in a Phase IIb human rhinovirus trial in asthmatic patients in March, 2012 (EvaluatePharma 2012). The readily available over the counter (OTC) drug cimetidine, approved for the treatment of reflux and "heartburn", has anti-viral properties as well, and may be a useful common cold treatment.

Several innovative and integrative strategies such as vitamin D, garlic, zinc, Astragalus, beta glucan, and probiotics have been shown in scientific studies to help manage symptom duration and intensity associated with the common cold (Maggini 2012).

2019 Novel Coronavirus

Over the last few decades, several new viruses have emerged as threats to human health around the globe. The most recent example is 2019 novel coronavirus, or 2019-nCoV.

2019-nCoV came to the attention of health authorities when it was identified as the cause of a small number of pneumonia cases in the city of Wuhan in Hubei province, China (WHO 2020). Since then, thousands of cases of 2019-nCoV illness have been identified in China, mainly in Hubei province, and international spread has been reported as travelers coming from China carry the virus worldwide (CDC 2020a).

Background

Coronaviruses are a large group of related viruses that cause many common human and animal infections (Li 2020). In humans, coronaviruses typically cause mild respiratory infections. Responsible for an estimated 10–30% of all upper respiratory tract infections, coronaviruses are among the most frequent causes of the common cold (Paules 2020). Over the last decade, new coronaviruses that cause potentially lethal respiratory diseases have emerged. These include severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (Su 2016).

The SARS pandemic, which lasted about nine months in 2002–2003, affected over 8,000 people in 29 world regions and caused fatality in almost 10% of cases. MERS, on the other hand, has been smoldering mainly on the Arabian Peninsula since 2012, infecting approximately 2,400 people and having a case fatality rate of nearly 35% (Hui 2020; Killerby 2020). For perspective, the fatality rate of influenza virus is typically much lower, reaching a maximum of about 0.2% in people over 75 years old; however, because of its high incidence, the number of deaths attributable to the flu worldwide averages between 291,000 and 646,000 annually (Iuliano 2018).

Although the characteristics of 2019-nCoV illness are still being elucidated, those most likely to contract 2019-nCoV are those in direct contact with other infected individuals. The most common presentation is fever and cough followed by flu-like symptoms, with rapid progression to fulminant pneumonia and death mainly in those over 70 years old. So far, the case fatality rate is 2.94% (Wang 2020). Experience with other new coronavirus outbreaks suggests those at greatest risk, in addition to the elderly, are likely to be those who are hospitalized, immunocompromised, or have a chronic disease (Hui 2020; Azhar 2019). In addition, health care workers have historically been at increased risk of developing and transmitting coronavirus infections (Judson 2019; Otter 2016).

Spread

Coronaviruses are highly adaptable and known to undergo host-switching. Several established human coronaviruses have evolved from bird or mammalian coronavirus origins (Corman 2018). For example, the human coronavirus associated with MERS is likely to have come from camels, though its origins may have been a bat coronavirus; the SARS coronavirus also appears to have originated in bats and was possibly transmitted by an intermediate mammalian host called a civet (Azhar 2019; Hui 2019). Although distinct from all other known coronaviruses, 2019-nCoV also appears to be closely related to a bat coronavirus (Chen 2020).

Once adapted to the human host, coronaviruses can become transmissible between humans. There are four possible routes of transmission: contact, droplet, aerosol, and oral-fecal (Shiu 2019).

  • Contact. Direct contact is the most likely route of transmission for coronaviruses such as those associated with SARS, MERS, and the current outbreak (Killerby 2020). In these cases, the virus is transferred when an uninfected individual comes into direct contact with an infected person who is actively shedding virus.
  • Droplet. In this form of viral spread, the virus is suspended in droplets emitted from the respiratory tract of an infected individual through a sneeze or cough and inhaled by nearby uninfected individuals. Another possibility is that droplets may land on or near uninfected individuals, be picked up by hands, and transferred to the respiratory tract through touching the nose, mouth, or eyes (Hui 2019). Interestingly, studies using SARS and MERS coronaviruses show they can remain viable on inanimate surfaces for long periods of time, even months, depending on the nature of the surface and environmental conditions (Otter 2016).
  • Aerosol. The aerosol route of transmission involves inhalation of airborne viruses, possibly at some distance from the infected person. Although this is less likely than direct contact or droplet transmission, studies in indoor environments and some case reports suggest this is a viable transmission route for SARS and MERS coronaviruses (Judson 2019; La Rosa 2013). Aerosol transmission appears to be an especially important concern in health care settings where aerosol-generating medical procedures may put health care workers and other patients at risk (Judson 2019).
  • Oral-fecal. The oral-fecal route involves viruses being shed through the feces (usually in people with diarrhea), contaminating surfaces and ultimately hands that can then introduce the virus to the respiratory tract. This is an uncommon but documented route of transmission for coronaviruses such as the SARS virus (Hui 2019).

Protective Measures

Below are some basic measures to consider in order to reduce your risk of contracting 2019-nCoV and other viral illnesses.

1. Avoid air travel to affected regions. Avoiding contact with infected individuals is the best way to protect yourself from 2019-nCoV. Since most of the cases are occurring in China at this time, the Centers for Disease Control and Prevention has issued a travel warning that recommends avoiding non-essential travel to China (CDC 2020b).

In addition, all air travel is associated with exposure to people and the infectious agents they carry. Outbreaks of infectious illnesses, including measles, influenza, SARS, and many others, aboard commercial flights have been documented (Mangili 2015; Hertzberg 2016). Therefore, avoiding air travel is a reasonable precaution for reducing your risk of viral infections in general, particularly if you have other vulnerabilities.

2. Wash your hands. Frequent hand washing is an important strategy for protecting against all types of infectious diseases. Studies in office and health care settings have further demonstrated strategic use of alcohol-based surface disinfectants and hand sanitizers can reduce viral spread by 85–94% (Kurgat 2019; Reynolds 2019).

3. Strengthen immunity. Optimal functioning of the immune system is vital for defending against all types of infections, from mild colds to dangerous influenza and life-threatening pneumonia. A nutrient-dense diet, regular exercise, adequate sleep, and stress management can all contribute to healthy immune function (Zapatera 2015). Other strategies for strengthening immunity and reducing risk of viral infections can be found in Life Extension’s Influenza, Pneumonia, and Immune Senescence protocols.

4. Consider a face mask. Findings from several studies suggest face masks, when used correctly, might slow the spread of viral infection by reducing infection risk in well people (MacIntyre 2015). One model of viral spread in a healthcare setting estimated face masks could reduce flu susceptibility by 3–10% (Blanco 2016). Face masks may work in part by inhibiting droplet spread and reducing touching of the nose and mouth with contaminated hands (Qualls 2017). It is also possible face mask-wearing by sick individuals may protect those in proximity, but the evidence to support this notion is sparse (Qualls 2017; MacIntyre 2016).

5. Disinfect surfaces. Coronaviruses can persist on inanimate surfaces like metal, glass, or plastic for up to nine days. Fortunately, coronaviruses can be inactivated with proper cleaning and disinfecting agents. Therefore, keeping surfaces clean and properly disinfected is important to limit the spread of infectious diseases caused by coronaviruses. A study published on February 6, 2020 found that coronaviruses on inanimate surfaces can be inactivated within one minute through disinfection with 62-71% ethanol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite (eg, bleach) (Kampf 2020).

Medications

Because there are no proven medical treatments for 2019-nCoV or other human coronaviruses, scientists are looking to both old and new antiviral drugs in search of effective therapies. Some, but not all, laboratory, animal, and preliminary human trials exploring the use of established antiviral medications against human coronaviruses have reported positive findings. This includes antiviral drugs used to treat human immunodeficiency virus (HIV) and hepatitis B and C, such as ribavirin (Ribasphere), lopinavir-ritonavir (Kaletra), and interferon beta-1b (Betaseron) (Sheahan 2020; Chu 2004; Dyall 2017). The antimalarial drug chloroquine (Aralen) has shown broad-spectrum antiviral effects in preclinical and clinical research, indicating its potential role in combined-drug approaches to treating emerging coronavirus infections (Dyall 2017).

Remdesivir is another antiviral drug that has shown promise against 2019-nCoV in preliminary pre-clinical studies. It is a prodrug of an adenosine analog that has potent antiviral activity against many RNA virus families (Agostini 2018). A 2018 in vitro study showed that remdesivir was efficacious against two strains of human endemic coronavirus (HCoV-OC43 and HCoV-229E) (Brown 2019). A drug screening study published on February 4th, 2020 showed remdesivir and chloroquine were both effective at inhibiting 2019-nCoV in vitro (Wang 2020). The Wall Street Journal published an article on January 31st indicating that the pharmaceutical company Gilead has entered into agreement with Chinese health authorities to conduct priority clinical trials to assess the efficacy of remdesivir in patients infected with 2019-nCoV (Walker 2020).

In the face of low efficacy and challenging adverse side effects of known medications, researchers are searching for new approaches. Immunotherapy using monoclonal antibodies could have a role in treating MERS, SARS, and other emerging coronavirus infections such as 2019-nCoV illness (Jin 2017), and novel compounds with anti-coronavirus activity are currently being developed and tested (Sheahan 2017).

Integrative Approaches

There are many integrative therapies with well-established antiviral and immune-modulating properties. Details regarding these therapies can be found in Life Extension’s Influenza, Pneumonia, and Immune Senescence protocols. The interventions described in these protocols, though not necessarily validated as effective specifically for coronavirus infections, are nevertheless advisable upon onset of symptoms of upper respiratory tract infections.

Below we highlight a few integrative interventions that have shown beneficial immune-enhancing effects in the context of viral upper respiratory tract infections.

  • Selenium. Selenium has important antioxidant, anti-inflammatory, and antiviral activities in the body, and deficiency is associated with increased risk of viral infection (Wrobel 2016). In patients with HIV infection, poor selenium status is correlated with increased mortality, and supplementation has been reported to slow progression of immune dysfunction and reduce hospital admissions (Wrobel 2016; Muzembo 2019). Some researchers have proposed that lack of selenium in regional soils may have contributed to the SARS outbreak in 2003 (Harthill 2011).
  • Probiotics. A growing body of evidence shows probiotic supplements with Bifidobacterium and Lactobacillus species can enhance antiviral immune activity and may reduce the occurrence, severity, and duration of viral respiratory tract infections such as influenza (Lenoir-Wijnkoop 2019; Mousa 2017).
  • Epigallocatechin gallate (EGCG). EGCG is a polyphenol from green tea. Because of its broad antiviral effects, EGCG has been proposed as a promising agent for preventing and treating viral infections such as SARS and MERS (Kaihatsu 2018; Hsu 2015).

3 Development and Progression of the Common Cold

While the common cold may be caused by over 200 distinct and continually evolving viral pathogens; rhinoviruses, coronaviruses and respiratory syncytial viruses appear to be some of the most common (Turner 2009; Nussenbaum 2010; Worrall 2011; CDC 2012C).

Infection occurs when the cold-causing virus comes into contact with mucous membranes in the nose or eyes. Common cold infections generally result in a non-specific acute inflammatory response that stimulates the release of various inflammatory cytokines and other immune mediators. In fact, many of the symptoms associated with the common cold are a result of inflammation caused by this immune response, rather than by the virus itself (Turner 2009; Turner 2011; Hayden 2011; Pappas 2009). For example, the release of a proinflammatory peptide called bradykinin is a major contributor to sore throat symptoms (Turner 2009; Proud 1988). Stuffy nose symptoms result from increased pooling of blood in nasal blood vessels and increased nasal secretions. Likewise, runny nose occurs due to enhanced permeability of nasal blood vessels, which allows serum to leak into the nasal mucosa (Turner 2011).

Although infection with a virus known to cause the common cold generates an adaptive immune response that helps protect against repeated infection by the same or very similar virus, the sheer volume of distinct viruses that can cause the common cold makes developing immunity against the common cold itself very challenging (Hayden 2011; Turner 2009, Turner 2011). However, infection by a cold virus can decrease the risk and severity of re-infection with the same virus (Turner 2009).

New Understanding of the Human Immune System Paves Way for Potential Common Cold Treatment

For at least the last 100 years it has been assumed that the ability of antibodies produced by the immune system to protect against pathogens ends at the cellular membrane. In other words, scientists have thought that once a virus enters a cell it escapes the attack of antibody-mediated immunity, leaving only one option to eliminate the virus – kill the cell that harbors it. However, emergent research suggests this is not the case.

A specialized protein within cells called TRIM21 has been shown to bind to virus-bound antibodies within the cell and initiate an intracellular immune response (McEwan 2011).

Researchers have proposed that delivery of exogenous TRIM21, perhaps as a nasal spray, may help up-regulate immunity against some cold-causing viral pathogens and eliminate them in as little as a few hours (Mallery 2010; Connor 2010).

Although more research is needed before these findings can be applied clinically, the discovery of an intracellular defense system against viruses opens the door to promising new interventions for the common cold and other viral diseases.

4 Common Cold Symptoms

The clinical symptoms of the common cold generally occur within 24-72 hours of infection, and typically begin with runny nose and a sore or "scratchy" throat. Sore throat symptoms usually subside by the 2nd or 3rd day of infection, after which nasal symptoms typically become the most bothersome (Turner 2009; Turner 2011; Hayden 2011; Nussenbaum 2010). Three out of every 10 people with the common cold may develop an unproductive cough, often beginning after the onset of nasal symptoms, and persisting as the cold resolves (Turner 2009; Turner 2011; Hayden 2011; Nussenbaum 2010). As a whole, these symptoms may last anywhere from 2 to 14 days, but most people recover within 7 to 10 days. Nasal symptoms lasting longer than 2 weeks may be due to seasonal allergies rather than the common cold (NIAID 2011b).

Occasionally, common cold infections are associated with other complications such as ear and/or sinus infection. The common cold has also been known to exacerbate certain diseases of the upper respiratory tract such as asthma, bronchitis, cystic fibrosis, and COPD. Patients who experience high fever, intense sinus pain, severely swollen glands, and/or cough that produces mucus (i.e., productive cough) may have a more serious illness, and should notify their health care provider immediately (NIAID 2011b; Turner 2011; Roxas 2007d; Niespodziana 2012).

Common Cold vs. The Flu: Comparison of Characteristics

Feature

Colds

Flu

Etiological Agent

>200 viral strains; rhinovirus most common

3 strains of influenza virus: influenza A, B, and C

Site of Infection

Upper respiratory tract

Entire respiratory system

Symptom Onset

Gradual: 1-3 days

Sudden: within a few hours

Fever, chills

Occasional, low grade (<101° F)

Characteristic, higher (>101° F),

lasting 2-4 days

Headache

Infrequent, usually mild

Characteristic, more severe

General aches, pains

Mild, if any

Characteristic, often severe and affecting the entire body

Sore throat

Common, usually mild

Sometimes present

Cough, chest congestion

Common; mild-to-moderate, with hacking, productive cough

Common; potentially severe dry, non-productive cough

Runny, stuffy nose

Very common, accompanied by bouts of sneezing

Sometimes present

Fatigue, weakness

Mild, if any

Usual, may be severe and last 2-3 weeks

Extreme exhaustion

Rarely

Frequent, usually in early stages of illness

Season

Year around, peaks in winter months

Most cases between November and February

Antibiotics helpful?

No, unless secondary bacterial infection develops

No, unless secondary bacterial infection develops

(Roxas 2007; MD Consult 2012c; Utah Dept. Health 2010; CDC 2011; Oklahoma State Dept. of Health 2011)

5 Common Cold Prevention

Suggestions for preventing the common cold include:

Avoid others while you have cold symptoms and are contagious (i.e., 2-7 days) - Depending on the offending virus, the common cold may be transmitted from one person to another via inhalation. This is because viral particles are small enough to be suspended in the air when an infected person coughs, sneezes, or blows their nose. Since some viruses can live for up to 3 hours on human skin, the cold can also be transmitted via direct contact with an infected person (NIAID 2011c; Turner 2011; NIH 2012A).

Infected individuals should direct their cough or sneeze into the inner crook of their elbow, rather than into their hand(s) or directly into the air - The contagious particles from a cough or sneeze occasionally land on environmental objects or surfaces, where rhinoviruses can also survive for up to 3 hours (NIH 2012a; Nicas 2008; NIAID 2011c).

Avoid touching eyes, nose, and/or mouth during cold outbreaks - For most people this task is extremely difficult, especially since the average person touches their face approximately 16 times per hour. Given that unconscious face touching is almost unavoidable, hand washing/sanitizing and using surface disinfectants to prevent the spread of the common cold is important (NIH 2012a; Nicas 2008; NIAID 2011c).

Lifestyle modifications such as exercising have proven to be effective at reducing the number of common cold infections (NIAID 2011c). Individuals who become infected with mild to moderate cases of the cold should continue their exercise routine, provided their symptoms are not body-wide (Simon 2012).

Adequate sleep quantity and quality are important for protecting against common cold – Sleep is known to modulate the immune responses through the production of regulatory cytokines (Teodorescu 2012; Walsh 2011).

When possible, limit your exposure to children (particularly via day-care centers) during peak cold season – Since children are much more likely to contract a cold than adults (6-8 colds/yr. vs. 2-4 colds/yr., respectively), the adult risk of infection increases with increased contact with children, especially in close quarters (Lissiman 2012; Turner 2009). If this cannot be avoided, you should take extra precautions to wash/sanitize your hands and disinfect surfaces that may be contaminated (NIH 2012a; Nicas 2008; NIAID 2011c).

6 Conventional Treatment

Although the common cold is caused by viral infection, due to the sheer volume of potential common cold viruses and treatment timing, targeted anti-viral drugs are not typically beneficial (Pappas 2009). In addition, antibacterial drugs (i.e., antibiotics) are of no benefit in the treatment of the common cold (Turner 2009), except for in severe cases involving complication such as secondary bacterial sinusitis (Nussenbaum 2010). In fact, the use of antibacterial medications for treating uncomplicated colds is likely to do more harm than good, as they can induce adverse reactions as well as contribute to the development of drug resistant pathogens (CDC 2012b).

Over-the-Counter Cold Medicines Nearly $3 billion worth of OTC cold medicines are purchased each year, but randomized trial evidence suggests minimal effectiveness (Turner 2009; De Sutter 2009; Barrett 2007).

The following list comprises commonly used over-the-counter cough and cold medications along with their specific indications (Turner 2009; Simasek 2007; Dealleaume 2009):

Oxymetazoline and pseudoephedrine – These drugs are alpha-adrenergic agents. When use topically or orally, these agents may help relieve stuffy nose symptoms by causing blood vessels to constrict (Atkins 2011). Decongestants like pseudoephedrine can increase blood pressure and should not be used by people with hypertension (Simasek 2007).

Diphenhydramine – Diphenhydramine blocks the effects of histamine in the body, which is a proinflammatory component of the immune system. It may be beneficial for treating runny nose, sneezing, coughing, and nausea (Turner 2009; Clinical Pharmacology 2012a; MD Consult 2012a). Diphenhydramine also causes sedation and may cause arrhythmia and/or tachycardia and so should be used with caution by people who have heart problems (Simasek 2007).

Dextromethorphan – Dextromethorphan is a cough suppressant drug. It appears to reduce coughing via several actions within the brain (Clinical Pharmacology 2012b; MD Consult 2012b). Potential side effects of dextromethorphan include confusion, excitability, gastrointestinal disturbances, irritability, nervousness, and sedation (Simasek 2007).

Mild Analgesics - Acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., aspirin, ibuprofen, and naproxen) are drugs that provide analgesic, fever-reducing, and anti-inflammatory effects. These drugs may help alleviate painful symptoms such as a sore throat or muscle pain associated with the common cold (Turner 2009). It is important to consider that acetaminophen is an ingredient in many OTC cold medicines and can be toxic if consumed in excess. Therefore, it is imperative to read the labels of cold medicines carefully to avoid excess consumption of acetaminophen. Life Extension suggests that at least 600 mg of N-acetyl cysteine be taken with each dose of acetaminophen to help the liver detoxify harmful metabolic derivatives of the drug. More information is available in the Acetaminophen and NSAID Toxicity protocol.

People taking combination cough and cold medicines should be conscious of all the ingredients and doses contained within (e.g., some products contain up to 5 distinct ingredients), and make sure that they are not duplicating therapy or taking more than is recommended (Mayo Clinic 2012; Erebara 2008). Given that over-the-counter drugs have not been demonstrated to be beneficial for the treatment of cold in young children and their potential for toxicity, these medications are not recommended for children under 4 (Turner 2009).

Protecting Against the Common Cold with a Stomach Acid Medication Cimetidine is an over-the-counter drug that blocks certain histamine receptors (i.e., histamine receptor type 2 antagonist); it is approved by the FDA for inhibition of gastric acid secretion. In addition to its usefulness for treating gastric or duodenal ulcers (Scheinfeld 2003; Kubecova 2011), cimetidine has also been shown to augment immune response against viral pathogens (Shin 2012; Arae 2011; Wang 2008; Zhang 2011; Wang 2008; Stefani 2009).

One of cimetidine's important actions is inhibition of suppressor T-cells, which are cells of the immune system that normally "turn down" the immune response (Wang 2008; Li 2011). In other words, taking cimetidine at the first sign of a cold may allow for a more robust immune response by countering the effects of these intrinsic immune regulators.

New Drug Significantly Reduces Cold Symptoms in Clinical Trial

Results of a phase II clinical trial show that a new antiviral, vapendavir, reduced symptoms of rhinovirus infection among people with asthma (EvaluatePharma 2012).

Vapendavir works by blocking entry of viruses into host cells, thereby preventing infection.

Compared to those who took a placebo, vapendavir recipients experienced significantly less cold symptoms during days 2 and 4 of infection, when symptoms are typically worst. Moreover, those who took the new drug experienced earlier improvement of symptoms compared to those who took a placebo (1.7 days vs. 2.5 days).

More trials are needed before vapendavir becomes widely available as a common cold treatment, but these early results are encouraging.

7 Targeted Nutritional Therapies

After infection, viruses causing the common cold multiply rapidly. While most people wait until their symptoms become unbearable, then use an over-the-counter medication, Life Extension recommends aggressive action when the viral count is still relatively low and symptoms are mild.

Vitamin D. Evidence suggests vitamin D has a significant role in the regulation of the human immune system, and may reduce the risk of certain bacterial and viral infections (Beard 2011; Grant 2010). Theoretically, vitamin D supplementation may produce a sufficient amount of cathelicidin (a naturally occurring antimicrobial and antiviral) to cure viral respiratory infections such as the common cold (Cannell 2008; Barlow 2011). Furthermore, data show that higher vitamin D levels are associated with a decreased risk of contracting a seasonal viral infection (Berry 2011; Cannell 2011). In a comprehensive review, researchers analyzed data from 10,933 participants in 25 randomized controlled trials looking at the effect of vitamin D on risk of acute respiratory infections, including common colds. The analysis found that those receiving daily or weekly vitamin D supplements, in doses ranging from 300 IU to 4000 IU per day, had a 19% reduction in acute respiratory infection risk, and those with vitamin D deficiency (levels below 25 nmol/L or 10 ng/mL) at the beginning of the trial experienced a greater protective effect. A risk reduction was not seen in participants who received individual large doses of vitamin D (30,000 IU or more), either once or at intervals of one to three months, whether alone or in addition to daily or weekly doses (Martineau 2017). Life Extension recommends an optimal 25-hydroxyvitamin D blood level of between 50 and 80 ng/ml.

Vitamin C. Evidence shows that vitamin C augments several aspects of the immune system and helps defend against infections (especially viral infections) (Ely 2007; Holt 2010; Heimer 2009; Khalid 2011). Vitamin C enhances the production and action of white blood cells; for example it increases the ability of neutrophils (a type of white blood cell) to attack and engulf viruses (Heimer 2009; Jariwalla 1996; Anderson 1984). Vitamin C has been shown to reduce the chances of catching a cold, and may reduce cold duration (Holt 2010; Hemila 2011). Upon review of clinical data from 2 studies, researchers found that using vitamin C (1000 mg) plus zinc (10 mg) during a cold could reduce runny nose symptoms by up to 27 % over 5 days of treatment compared to placebo (Maggini 2012).

Zinc – Zinc helps maintain a healthy immune system, and zinc deficiency has been linked to significant immune impairment and susceptibility to infections (Roxas 2007; Maggini 2012). Unfortunately, zinc deficiency is a common problem affecting approximately 2 billion people worldwide, even many people in Western populations. Correcting zinc deficiency through supplementation has been shown to bolster aspects of the immune system involved in fighting viral infections (Maggini 2012; Sandstead 2010; Pae 2012). Zinc's antiviral properties may come from its ability to prevent the rhinovirus from attaching to cells in the nasal passages. In addition, zinc has been shown to prevent viral replication, reduce histamine release, and inhibit the production of other inflammatory mediators (Singh 2011).

A comprehensive review concluded that zinc supplementation was associated with a significant reduction in the duration and severity of the common cold (when administered within 24 hours of onset of symptoms). It was also found that zinc supplementation over 5 months was helpful for preventing the common cold (Singh 2011). Life Extension Magazine® published a comprehensive overview of the evidence suggesting that zinc acetate lozenges dissolved in the mouth every two waking hours may be an ideal approach during the early stages of the common cold.

DHEA. Dehydroepiandrosterone (DHEA) is a steroid hormone synthesized by the adrenal gland. Research has revealed that DHEA possesses powerful immune-enhancing and antiviral properties, and can enhance resistance to many different experimental infections (Romanutti 2010; Torres 2012; Kuehn 2011; Roxas 2007). DHEA accomplishes this in part by modulating several aspects of the immune system. For example, administering 50 mg of DHEA daily to an elderly population resulted in an increase in natural killer cell activity, a 62% increase in B cell activity and a 40% increase in T cell activity, all of which are important for defending against infectious pathogens (Roxas 2007).

DHEA supplementation is likely to be especially important among the aging and elderly, since DHEA levels decline sharply with age (Roxas 2007; Khorram 1997).

Melatonin. Melatonin is a hormone produced in the brain and the gut. It helps regulate the sleep-wake cycle and is a powerful antioxidant. Research indicates that melatonin helps combat many types of viral infections (Srinivasan 2012; Arushanian 2002; Boga 2012). For example, melatonin appears to "prime" the immune system by interacting with specialized immune cells called "T-helper cells", allowing for a more efficient immune response against pathogens. Furthermore, melatonin administration is also associated with an increased production of antibodies (Bonilla 2004).

Melatonin's role as an antioxidant may be helpful during a cold as well, since most viral infections are associated with high amounts of oxidative stress (Boga 2012). This may be especially true for elderly populations, since these patients frequently experience age-related impairment of the immune system, which coincides with declining melatonin concentrations (Srinivasan 2005).

Astragalus membranaceus. Astragalus membranaceus is a Chinese herb that contains a number of immune-stimulating ingredients such as polysaccharides, flavonoids, trace minerals, and amino acids. While it has been traditionally used to treat colds and flu as well as for increasing stamina and overall vitality, much of the research performed on Astragalus membranaceus is focused on its application for treating immune deficiency conditions (Roxas 2007; AMR 2003). In a clinical study comparing various natural products (i.e., echinacea, astragalus membranaceus, and licorice), Astragalus membranaceus demonstrated the strongest ability to activate immune cells (Roxas 2007).

Elderberry. Elderberry, also known as Sambucus nigra, has been used for its medicinal properties since at least 400 BC (Krawitz 2011; Roxas 2007). The purplish-black fruits of the elderberry plant are a rich source of antioxidants, and have long been considered a folk remedy for the treatment of influenza as well as the common cold (Ozgen 2010; Zakay-Rones 2004). Even today, elderberry extracts are commonly employed as an alternative to conventional drugs for the management of a variety of viral infections and are recognized as supportive agents against common cold (Krawitz 2011). Researchers believe that elderberry fights colds by activating white blood cells that engulf pathogens. The German Commission E (a therapeutic guide for the safety and efficacy of herbal products) has identified the constituents of elderberry as effective for the relief of colds (Roxas 2007).

Garlic. Garlic (i.e., allium sativum) has been traditionally used for both its culinary and therapeutic properties (Lissiman 2012). A clinical survey found that garlic is one of the most common herbs used for its medicinal properties including for the treatment of colds, flu, and cough (Zhang 2008). When raw garlic is chopped or chewed, it releases an active organo-sulfur compound called allicin, which has demonstrated antiviral activity against rhinovirus and a variety of other pathogens (Nahas 2011). While studies evaluating the use of garlic/allicin for the treatment of the common cold are lacking, evidence suggests it may be useful for the prevention of such infections (Nahas 2011). For example, one clinical study demonstrated that an allicin-containing garlic supplement taken once daily (over a 12-week period) was associated with 65% fewer colds than the placebo group (24 vs. 65). When compared to placebo, garlic/allicin supplementation was also linked to 70% reduction in symptom duration (~ 1.5 vs. 5 days) (Josling 2001).

Andrographis. Andrographis paniculata has been effectively used among Asian cultures for the treatment of colds for centuries (Chandrasekaran 2009; Ozolua 2011; Ji 2005; Akbar 2011; Valdiani 2012). It is reported to have anti-inflammatory, blood pressure lowering, antiviral, and immune-stimulant properties (Yang 2010). A 2009 study found that an extract of Andrographis enhanced immune function as well as reversed drug-induced immunosuppression (Naik 2009). Accumulating evidence suggests that Andrographis paniculata is effective as an alternative treatment option for the common cold (Coon 2004; Poolsup 2004; Kligler 2006). For example, a 2010 study found that a standardized extract of Andrographis paniculata was more than twice as effective as placebo in reducing symptoms of upper respiratory tract infections (Saxena 2010). Preliminary evidence suggests that Andrographis paniculata may be effective for the prevention of colds as well (Coon 2004).

Lactoferrin. Lactoferrin is an iron-binding protein found in milk. It is a powerful immune modulator and has shown marked ability to fight bacteria, fungi, protozoa, and viruses (Roxas 2007; Orsi 2004; Lonnerdal 2009). Laboratory studies reveal lactoferrin inhibits viral infection by interfering with the ability of certain viruses to bind to cell receptor sites and prevents entry of viruses into host cells (Waarts 2005; Berlutti 2011). In addition, lactoferrin may be beneficial for alleviating the symptoms or complications of viral infections like the common cold, because it suppresses free radical-mediated damage (Roxas 2007).

Beta-glucan. Beta-glucans are naturally occurring glucose polymers that constitute the cell walls of certain plants and pathogenic agents (Akramiene 2007). These polysaccharides have been shown to increase host immune defense, and are associated with enhancing macrophage and natural killer cell function (Pence 2012; Akramiene 2007). Beta glucans also appear to mitigate the symptoms of the common cold. The Montana Center for Work Physiology and Exercise Metabolism examined beta glucans' ability to mitigate upper respiratory infections in a single blind, randomized trial in 2008. Participants who consumed beta-glucans had 23% fewer upper respiratory tract infections, compared to the group taking a placebo (PRNewswire 2008).

Probiotics. Probiotics are defined as living microorganisms (i.e., bacteria and fungi) that confer a health benefit to the host when administered in adequate amounts (Gilliland 2001; MacDonald 2010). Clinical studies suggest that certain probiotics may help prevent viral respiratory tract infections such as the common cold by enhancing the immune system. Some probiotics are associated with a reduction in severity and duration of symptoms caused by common upper respiratory tract infections (de Vrese 2008; MacDonald 2010; Wolvers 2010; Vouloumanou 2009; Baron 2009; Leyer 2009). Probiotics may be useful for managing infectious diseases because of their potential for stabilizing the micro-flora of the gut, enhancing resistance against pathogenic colonization, and modulating immune functions (Wolvers 2010; Kimmel 2010; Baron 2009). A 2011 clinical study found that a probiotic lactobacilli was able to strengthen the body's immune defense against viral infections and reduce the risk of acquiring the common cold (Berggren 2011). Furthermore, the consumption of yogurt fermented with Lactobacillus augmented natural killer cell activity and reduced the risk of catching common cold infections among the elderly (Makino 2010).

Echinacea. Echinacea is an herb that was first utilized for its medicinal value by the Native Americans in the treatment of cough, sore throat, and tonsillitis (Caruso 2005). Today, echinacea represents one of the most popular herbs used for the treatment and prevention of upper respiratory tract infections (like the common cold) in both European and American markets (Tierra 2007; Woelkart 2008; Toselli 2009). Clinical evidence shows that echinacea has beneficial effects on the common cold, including reduced severity and duration of cold symptoms, as well as increases in monocytes, neutrophils, natural killer (NK) cells, and total white blood cell count (Roxas 2007). A 2010 clinical study found that a standardized extract of E. purpurea was able reduce the risk of common cold among athletes (Ross 2010).

Honey. Honey has been used since ancient times as a cough and cold remedy in some countries (Pourahmad 2009). Studies have shown that honey possesses antimicrobial properties and helps combat infection in a variety of clinical settings (Al-Waili 2011). Clinical trials have compared the efficacy of honey to that of placebo and several conventional medicines for relieving symptoms of the common cold (Pourahmad 2009). Evidence suggests that honey can relieve symptoms of the common cold in adults and children more effectively than some, but not all, conventional medicines (Heppermann 2009; Paul 2007; Oduwole 2012; Cohen 2012).

Enzymatically modified rice bran. Enzymatically modified rice bran is made by fermenting rice bran with enzymes extracted from the shiitake mushroom (Lentinus edodes). Through the fermentation process, immunologically active polysaccharides, including one called arabinoxylan, become more bioavailable (Choi 2014).

Animal research provides support for the immune-stimulating ability of enzymatically modified rice bran. In an experimental model of immune senescence using aged mice, treatment with enzymatically modified rice bran led to increased NK cell activity (Ghoneum, Abedi 2004). And, in a study in rats, immune cells from those fed enzymatically modified rice bran for two weeks exhibited a stronger response to an immune challenge (Giese 2008).

A number of laboratory studies further demonstrate the immune-enhancing effects of enzymatically modified rice bran. Human natural killer (NK) cells treated with fermented rice bran extract increased their production of the immune-stimulating cytokines interferon-gamma and tumor necrosis factor-alpha (Ghoneum 2000). Human monocytes, macrophages, and neutrophils have been shown to increase their phagocytic activity (ie, engulfing and digestion of foreign substances) upon treatment with enzymatically modified rice bran (Ghoneum, Matsuura 2004; Ghoneum 2008). Enzymatically modified rice bran was also found to stimulate maturation and increase activity in human immature dendritic cells, which are immune cells that help activate other immune cells (Cholujova 2009; Ghoneum 2011; Ghoneum 2014).

Arabinoxylan from enzymatically modified rice bran may protect against the common cold in older people. In healthy individuals, arabinoxylan increased levels of interferon-gamma (Choi 2014), a cytokine essential to the body’s antiviral defenses (Chesler 2002). Arabinoxylan was found in one study to protect against upper respiratory viral infections (common colds) in older people. In a double-blind, placebo-controlled, crossover trial, 36 subjects between 70 and 95 years of age received both 500 mg arabinoxylan and placebo, each for six weeks. Scores measuring total common cold symptoms were three times higher and duration of symptoms twice as long in participants during the placebo phase compared with the arabinoxylan phase. In those with low NK cell activity, the increase in NK cell activity was more than double in the arabinoxylan group compared with placebo (Maeda 2004).

Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the therapies discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. Life Extension has not performed independent verification of the data contained in the referenced materials, and expressly disclaims responsibility for any error in the literature.

Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, . . . Denison MR. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio. 2018;9(2):e00221-00218.

Akbar S. Andrographispaniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. 2011;16(1):66-77.

Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E. Effects of beta-glucans on the immune system. Medicina. 2007;43(8):597-606.

Albalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database Syst Rev. 2011;6(7).

Al-Waili NS, Salom K, Butler G, et al. Honey and Microbial Infections: A Review Supporting the Use of Honey for Microbial Control. [In eng] J Med Food. 2011 Oct; 14(10): 1079-96.

AMR. Astragalusmembranaceus.Monograph.Altern Med Rev. 2003;8(1):72-77.

Anderson R. The Immunostimulatory, Antiinflammatory and Anti-Allergic Properties of Ascorbate. [In eng] AdvNutr Res. 1984 6(19-45.

Arae K, Oboki K, Ohno T, et al. Cimetidine enhances antigen-specific IgE and Th2 cytokine production. Allergol Int. 2011;60(3):339-344.

Arushanian EB, Beier EV. [Immunotropic properties of pineal melatonin].EkspKlinFarmakol. 2002;65(5):73-80.

Atkins D. (2011) Chapter 136: Principles of Treatment of Allergic Disease (pg. 768). In: Kliegman R. (Ed.), Nelson Textbook of Pediatrics (19th ed.) Saunders, An Imprint of Elsevier.

Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East Respiratory Syndrome (MERS). Infect Dis Clin North Am. 2019;33(4):891-905.

Barlow PG, Svoboda P, Mackellar A, et al. Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin Ll-37. [In eng] PLoS One. 2011 6(10): e25333.

Baron M. A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med. 2009;121(2):114-118.

Barrett B, Harahan B, Brown D, Zhang Z, Brown R. Sufficiently important difference for common cold: severity reduction. Ann Fam Med. 2007;5(3):216-223.

Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J ClinVirol. 2011;50(3):194-200.

Berggren A, LazouAhren I, Larsson N, Onning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2011;50(3):203-210.

Berlutti F, Pantanella F, Natalizi T, et al. Antiviral Properties of Lactoferrin--a Natural Immunity Molecule. [In eng] Molecules. 2011 16(8): 6992-7018.

Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr. 2011;106(9):1433-40.

Blanco N, Eisenberg MC, Stillwell T, Foxman B. What Transmission Precautions Best Control Influenza Spread in a Hospital? Am J Epidemiol. 2016;183(11):1045-1054.

Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ. Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"? Rev Med Virol. 2012;18(10).

Bonilla E, Valero N, Chacin-Bonilla L, Medina-Leendertz S. Melatonin and viral infections. J Pineal Res. 2004;36(2):73-79.

Brown AJ, Won JJ, Graham RL, Dinnon KH, 3rd, Sims AC, Feng JY, . . . Sheahan TP. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral research. 2019;169:104541-104541.

Cannell JJ, Hollis BW. Use of vitamin D in clinical practice.Altern Med Rev. 2008;13(1):6-20.

Cannell JJ. The difference between a prophet and a madman.Br J Nutr. 2011;106(9):1317-8.

Caruso TJ, Gwaltney JM, Jr. Treatment of the common cold with echinacea: a structured review. Clin Infect Dis. 2005;40(6):807-810.

CDC (Centers for Disease Control and Prevention) Antibiotics Aren't Always the Answer. Last updated Feb. 27, 2012b. Accessed 7/25/12 at: http://www.cdc.gov/Features/GetSmart/

CDC (Centers for Disease Control and Prevention). Cold Versus Flu. 2/8/2011. Available at: http://www.cdc.gov/flu/about/qa/coldflu.htm. Accessed 8/24/2012.

CDC. Centers for Disease Control and Prevention. 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. Available at https://www.cdc.gov/coronavirus/2019-ncov/summary.html. Last undated January 28, 2020a. Accessed January 29, 2020.

CDC. Center for Disease Control and Prevention. Travelers’ Health: China Traveler View. Available at https://wwwnc.cdc.gov/travel/destinations/traveler/none/china. Last updated 01/27/2020b. Accessed 01/30/2020.

CDC. Common Cold and Runny Nose. 5/1/2012a. Available at: http://www.cdc.gov/getsmart/antibiotic-use/URI/colds.html Accessed 8/24/2012.

Chandrasekaran CV, Thiyagarajan P, Sundarajan K, et al. Evaluation of the genotoxic potential and acute oral toxicity of standardized extract of Andrographispaniculata (KalmCold). Food ChemToxicol. 2009;47(8):1892-1902.

Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020.

Chesler DA, Reiss CS. The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine & growth factor reviews.Dec 2002;13(6):441-454.

Choi JY, Paik DJ, Kwon DY, Park Y. Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-gamma activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study. Nutrition journal.2014;13:35.

Cholujova D, Jakubikova J, Sedlak J. BioBran-augmented maturation of human monocyte-derived dendritic cells. Neoplasma.2009;56(2):89-95.

Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252-256.

Clinical Pharmacology. (2012a) Diphenhydramine: drug monograph.

Clinical Pharmacology. (2012b) Dextromethorphan: drug monograph.

Cohen HA, Rozen J, Kristal H, et al. Effect of Honey on Nocturnal Cough and Sleep Quality: A Double-Blind, Randomized, Placebo-Controlled Study. [In Eng] Pediatrics. 2012 Aug 6;

Connor S. A cure for the common cold may finally be achieved as a result of a remarkable discovery in a Cambridge laboratory. 11/2/2010. Available at: http://www.independent.co.uk/news/science/a-cure-for-the-common-cold-may-finally-be-achieved-as-a-result-of-a-remarkable-discovery-in-a-cambridge-laboratory-2122607.html Accessed 8/30/2012.

Coon JT, Ernst E. Andrographispaniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med. 2004;70(4):293-298.

Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res. 2018;100:163-188.

De Sutter AI, Lemiengre M, Campbell H. WITHDRAWN: Antihistamines for the common cold. Cochrane Database Syst Rev. 2009;7(4).

de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. AdvBiochemEngBiotechnol. 2008;111:1-66.

Dealleaume L, Tweed B, Neher JO. Do OTC remedies relieve cough in acute URIs? J FamPract. 2009;58(10):559a-c.

Dyall J, Gross R, Kindrachuk J, et al. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies. Drugs. 2017;77(18):1935-1966.

Ely JT. Ascorbic acid role in containment of the world avian flu pandemic.ExpBiol Med. 2007;232(7):847-851.

Erebara A, Bozzo P, Einarson A, Koren G. Treating the common cold during pregnancy. Can Fam Physician. 2008;54(5):687-689.

EvaluatePharma. Biota Announces Positive Phase IIb Data for Asthmatic Patients With Human Rhinovirus Infection (HRV). March 28, 2012. Available at: http://www.evaluatepharma.com/Universal/View.aspx?type=Story&id=284969 Accessed 8/30/2012.

Ghoneum M, Abedi S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). The Journal of pharmacy and pharmacology.Dec 2004;56(12):1581-1588.

Ghoneum M, Agrawal S. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran). International journal of immunopathology and pharmacology.Oct-Dec 2011;24(4):941-948.

Ghoneum M, Agrawal S. Mgn-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells. International journal of immunopathology and pharmacology.Oct-Dec 2014;27(4):523-530.

Ghoneum M, Jewett A. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer detection and prevention.2000;24(4):314-324.

Ghoneum M, Matsuura M. Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). International journal of immunopathology and pharmacology. Sep-Dec 2004;17(3):283-292.

Ghoneum M, Matsuura M, Gollapudi S. Modified arabinoxylan rice bran (MGN3/Biobran) enhances intracellular killing of microbes by human phagocytic cells in vitro. International journal of immunopathology and pharmacology.Jan-Mar 2008;21(1):87-95.

Giese S, Sabell GR, Coussons-Read M. Impact of ingestion of rice bran and shitake mushroom extract on lymphocyte function and cytokine production in healthy rats. Journal of dietary supplements.2008;5(1):47-61.

Gilliland SE, Morelli L, Reid G. Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Rome, Italy: Food and Agriculture Organization of the United Nations World Health Organization; 2001. Available at: ftp://ftp.fao.org/es/esn/food/probio_report_en.pdf. Accessed July 19, 2012

Grant WB, Goldstein M, Mascitelli L. Ample evidence exists from human studies that vitamin D reduces the risk of selected bacterial and viral infections. ExpBiol Med. 2010;235(12):1395-1396.

Harthill M. Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol Trace Elem Res. 2011;143(3):1325-1336.

Hayden G. (2011) Chapter 371: The Common Cold (pg. 1434). In: Kliegman R. (Ed.), Nelson Textbook of Pediatrics (19th ed.) Saunders, An Imprint of Elsevier.

Heimer KA, Hart AM, Martin LG, Rubio-Wallace S. Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold. J Am Acad Nurse Pract. 2009;21(5):295-300.

Hemila H. The effect of vitamin C on the common cold: J Pharm Pract. 2011 Apr;24(2):241-2.

Heppermann B. Towards Evidence Based Emergency Medicine: Best Bets from the Manchester Royal Infirmary. Bet 3. Honey for the Symptomatic Relief of Cough in Children with Upper Respiratory Tract Infections. [In eng] Emerg Med J. 2009 Jul; 26(7): 522-3.

Hertzberg VS, Weiss H. On the 2-Row Rule for Infectious Disease Transmission on Aircraft. Ann Glob Health. 2016;82(5):819-823.

Holt S. Hype around high-dose vitamin C is unjustified: N Z Med J. 2010 Oct 15;123(1324):109-10.

Hsu CH, Hwang KC, Chao CL, et al. An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study. Evid Based Complement Alternat Med. 2008;5(3):355-362.

Hsu S. Compounds Derived from Epigallocatechin-3-Gallate (EGCG) as a Novel Approach to the Prevention of Viral Infections. Inflamm Allergy Drug Targets. 2015;14(1):13-18.

Hui DS, E IA, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-266.

Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019;33(4):869-889.

Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-1300.

Jariwalla RJ, and Harakeh S. Antiviral and Immunomodulatory Activities of Ascorbic Acid. [In eng] SubcellBiochem. 1996 25(213-31.

Ji LL, Wang Z, Dong F, Zhang WB, Wang ZT. Andrograpanin, a compound isolated from anti-inflammatory traditional Chinese medicine Andrographispaniculata, enhances chemokine SDF-1alpha-induced leukocytes chemotaxis. J Cell Biochem. 2005;95(5):970-978.

Jin Y, Lei C, Hu D, Dimitrov DS, Ying T. Human monoclonal antibodies as candidate therapeutics against emerging viruses. Front Med. 2017;11(4):462-470.

Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. AdvTher. 2001;18(4):189-193.

Judson SD, Munster VJ. Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures. Viruses. 2019;11(10).

Kaihatsu K, Yamabe M, Ebara Y. Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters. Molecules. 2018;23(10).

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. The Journal of hospital infection. 2020:S0195-6701(0120)30046-30043.

Khalid U, Saleem T, Shah S. Therapeutic and prophylactic use of vitamin C for the common cold: J Pak Med Assoc. 2011 Dec;61(12):1252.

Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A BiolSci Med Sci. 1997;52(1):M1-7.

Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East Respiratory Syndrome Coronavirus Transmission. Emerg Infect Dis. 2020;26(2):191-198.

Kimmel M, Keller D, Farmer S, Warrino DE. A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers. Methods Find ExpClinPharmacol. 2010;32(2):129-132.

Kligler B, Ulbricht C, Basch E, et al. Andrographispaniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration. Explore. 2006;2(1):25-29.

Krawitz C, Mraheil MA, Stein M, et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011;11:16.

Kubecova M, Kolostova K, Pinterova D, Kacprzak G, Bobek V. Cimetidine: an anticancer drug? Eur J Pharm Sci. 2011;42(5):439-444.

Kuehn CC, Oliveira LG, Santos CD, Augusto MB, Toldo MP, do Prado JC, Jr. Prior and concomitant dehydroepiandrosterone treatment affects immunologic response of cultured macrophages infected with Trypanosomacruzi in vitro? Vet Parasitol. 2011;177(3-4):242-246.

Kurgat EK, Sexton JD, Garavito F, et al. Impact of a hygiene intervention on virus spread in an office building. Int J Hyg Environ Health. 2019;222(3):479-485.

La Rosa G, Fratini M, Della Libera S, Iaconelli M, Muscillo M. Viral infections acquired indoors through airborne, droplet or contact transmission. Ann Ist Super Sanita. 2013;49(2):124-132.

Lenoir-Wijnkoop I, Merenstein D, Korchagina D, Broholm C, Sanders ME, Tancredi D. Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study. Front Pharmacol. 2019;10:980.

Leung PC. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. Am J Chin Med. 2007;35(4):575-581.

Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics. August 2009 2009;124(2):e172-e179.

Li G, Fan Y, Lai Y, et al. Coronavirus Infections and Immune Responses. J Med Virol. 2020.

Li MJ, Lei JH, Wang T, et al. Cimetidine Enhances the Protective Effect of Gst DNA Vaccine against SchistosomaJaponicum. [In eng] ExpParasitol. 2011 Aug; 128(4): 427-32.

Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. Cochrane Database Syst Rev. 2012;14(3).

Lonnerdal B. Nutritional roles of lactoferrin.CurrOpinClinNutrMetab Care. 2009;12(3):293-297.

MacDonald TT, Bell I. Probiotics and the immune response to vaccines. ProcNutr Soc. 2010;69(3):442-446.

MacIntyre CR, Chughtai AA. Facemasks for the prevention of infection in healthcare and community settings. Bmj. 2015;350:h694.

MacIntyre CR, Zhang Y, Chughtai AA, et al. Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness. BMJ Open. 2016;6(12):e012330.

Maeda H, Ichihashi K, Fujii T, Omura K, Zhu X, Anazawa M, Tazawa K. Oral administration of hydrolyzed rice bran prevents the common cold syndrome in the elderly based on its immunomodulatory action. BioFactors (Oxford, England).2004;21(1-4):185-187.

Maggini S, Beveridge S, and Suter M. A combination of high-dose vitamin C plus zinc for the common cold. J Int Med Res. 2012;40(1):28-42.

Makino S, Ikegami S, Kume A, Horiuchi H, Sasaki H, Orii N. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr. 2010;104(7):998-1006.

Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proceedings of the National Academy of Sciences of the United States of America. Nov 16 2010;107(46):19985-19990.

Mangili A, Vindenes T, Gendreau M. Infectious Risks of Air Travel. Microbiol Spectr. 2015;3(5).

Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017 Feb 15;356:i6583.

Mayo Clinic.Common cold. Last updated Feb. 22, 2011. Accessed 8/17/12 at: http://www.mayoclinic.com/health/common-cold/DS00056/

Mayo Clinic.Cough and Cold Combinations (Oral Route). Last updated July 1, 2012. Accessed 7/25/12 at: http://www.mayoclinic.com/health/drug-information/DR602361

McEwan WA, Mallery DL, Rhodes DA, Trowsdale J, James LC.Intracellular antibody-mediated immunity and the role of TRIM21.BioEssays : news and reviews in molecular, cellular and developmental biology. Nov 2011;33(11):803-809.

MD Consult. Dextromethorphan. Available at: http://www.mdconsult.com/das/pharm/body/353603642-6/0/full/179 Accessed: 8/24/2012b.

MD Consult. Diphenhydramine. Available at: http://www.mdconsult.com/das/pharm/body/353603642-3/0/full/197 Accessed 8/24/2012a.

MD Consult. Influenza. Available at: http://www.mdconsult.com/das/pdxmd/body/353653056-3/0?type=med&eid=9-u1.0-_1_mt_1014549 Accessed. 8/24/2012c.

Mousa HA. Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies. J Evid Based Complementary Altern Med. 2017;22(1):166-174.

Muzembo BA, Ngatu NR, Januka K, et al. Selenium supplementation in HIV-infected individuals: A systematic review of randomized controlled trials. Clin Nutr ESPEN. 2019;34:1-7.

Nahas R, Balla A. Complementary and alternative medicine for prevention and treatment of the common cold. Can Fam Physician. 2011;57(1):31-36.

Naik SR, Hule A. Evaluation of immunomodulatory activity of an extract of andrographolides from Andographispaniculata. Planta Med. 2009;75(8):785-791.

NIAID (National Institute of Allergy and Infectious Diseases). Common Cold: Symptoms. Updated February 11, 2011b. http://www.niaid.nih.gov/topics/commoncold/Pages/symptoms.aspx

NIAID (National Institute of Allergy and Infectious Diseases). Common Cold: Prevention. Last Updated April 13, 2011c. http://www.niaid.nih.gov/topics/commoncold/Pages/prevention.aspx

NIAID (National Institute of Allergy and Infectious Diseases). Topics: Flu: Understanding Flu: Definitions and Overview. Updated August 08, 2011a. Accessed 7/1/12. Available at: http://www.niaid.nih.gov/topics/Flu/understandingFlu/Pages/definitionsOverview.aspx

Nicas M, Best D.A study quantifying the hand-to-face contact rate and its potential application to predicting respiratory tract infection. J Occup Environ Hyg. 2008;5(6):347-352.

Niespodziana K, Napora K, Cabauatan C, et al. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. Faseb J. 2012;26(3):1001-1008.

NIH (National Institutes of Health) MedlinePlus: Common Cold. Last updated July 18, 2012. Accessed July 24, 2012b at: http://www.nlm.nih.gov/medlineplus/commoncold.html

NIH (National Institutes of Health) MedlinePlus: Common Cold. Last updated July 27, 2012. Accessed July 30, 2012a at: http://www.nlm.nih.gov/medlineplus/ency/article/000678.htm

Nussenbaum B. (2010) Chapter 13: Pharyngitis in Adults: Common Cold (pg. 196). In: Flint P. (Ed.) Cummings Otolaryngology: Head & Neck Surgery (5th ed.) Mosby, An Imprint of Elsevier.

Oduwole O, Meremikwu MM, Oyo-Ita A, et al. Honey for Acute Cough in Children. [In eng] Cochrane Database Syst Rev. 2012 3(CD007094.

Oklahoma State Dept. of Health. Cold vs. Flu: Know the difference. 09/2011. Available at: http://www.ok.gov/health/documents/Cold%20vs%20Flu%20Know%20the%20Difference.pdf Accessed: 8/27/2012.

Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals. 2004;17(3):189-196.

Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92(3):235-250.

Ozgen M, Scheerens JC, Reese RN, Miller RA. Total phenolic, anthocyanin contents and antioxidant capacity of selected elderberry (Sambucuscanadensis L.) accessions.Pharmacogn Mag. 2010;6(23):198-203.

Ozolua RI, Adejayan A, Aigbe OP, Uwaya DO, Argawal A. Some Characteristic Relaxant Effects of Aqueous Leaf Extract of Andrographispaniculata and Andrographolide on Guinea pig Tracheal Rings. Niger J Physiol Sci. 2011;26(2):119-124.

Pae M, Meydani SN, Wu D. The role of nutrition in enhancing immunity in aging. Aging Dis. 2012;3(1):91-129.

Pappas D. (2009) Chapter 28: The Common Cold (pg. 204). In: Long S. (Ed.) Principles and Practice of Pediatric Infectious Diseases Revised Reprint (3rd ed.) Churchill Livingstone, An Imprint of Elsevier.

Paul IM, Beiler J, McMonagle A, et al. Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. [In eng] Arch PediatrAdolesc Med. 2007 Dec; 161(12): 1140-6.

Paules CI, Marston HD, Fauci AS. Coronavirus Infections—More Than Just the Common Cold. JAMA. 2020.

Pence BD, Hester SN, Donovan SM, Woods JA. Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice. Immunol Invest. 2012;41(3):275-289.

Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. Andrographispaniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. J Clin Pharm Ther. 2004;29(1):37-45.

Pourahmad M, and Sobhanian S. Effect of Honey on the Common Cold. [In eng] Arch Med Res. 2009 Apr; 40(3): 224-5.

PRNewswire (2008). Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study. Available at: http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-29-2008/0004822407&EDATE= Accessed 8/22/2012.

Proud D, Reynolds CJ, Lacapra S, et al. Nasal Provocation with Bradykinin Induces Symptoms of Rhinitis and a Sore Throat. [In eng] Am Rev Respir Dis. 1988 Mar; 137(3): 613-6.

Qualls N, Levitt A, Kanade N, et al. Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017. MMWR Recomm Rep. 2017;66(1):1-34.

Reynolds KA, Sexton JD, Pivo T, Humphrey K, Leslie RA, Gerba CP. Microbial transmission in an outpatient clinic and impact of an intervention with an ethanol-based disinfectant. Am J Infect Control. 2019;47(2):128-132.

Romanutti C, Bruttomesso AC, Castilla V, Galagovsky LR, Wachsman MB. Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives.Chemotherapy. 2010;56(2):158-165.

Ross SM. A standardized Echinacea extract demonstrates efficacy in the prevention and treatment of colds in athletes. Holist NursPract. 2010;24(2):107-109.

Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev. 2007;12(1):25-48.

Sandstead HH, Prasad AS. Zinc intake and resistance to H1N1 influenza: Am J Public Health. 2010 Jun;100(6):970-1. Epub 2010 Apr 15.

Saxena RC, Singh R, Kumar P, et al. A randomized double blind placebo controlled clinical evaluation of extract of Andrographispaniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. 2010;17(3-4):178-185.

Scheinfeld N. Cimetidine: a review of the recent developments and reports in cutaneous medicine. Dermatol Online J. 2003;9(2):4.

Shefrin AE, Goldman RD. Use of over-the-counter cough and cold medications in children. Can Fam Physician. 2009;55(11):1081-1083.

Sheahan TP, Sims AC, Graham RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9(396).

Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11(1):222.

Shin JS, Abah U. Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery? Interact CardiovascThorac Surg. 2012;14(5):622-628.

Shiu EYC, Leung NHL, Cowling BJ. Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. Curr Opin Infect Dis. 2019;32(4):372-379.

Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician. 2007;75(4):515-520.

Simon HB. On call. I do my best to exercise every day, either walking two miles in good weather or riding my exercise bike for 30 minutes on wet or cold days. Should I keep going when I catch a cold, or would I be better off resting? HarvMens Health Watch. 2012;16(7):8.

Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2011;16(2):cd001364.

Srinivasan V, Maestroni G, Cardinali D, Esquifino A, Perumal SP, Miller S. Melatonin, immune function and aging. Immunity & Ageing. 2005;2(1):17.

Srinivasan V, Mohamed M, Kato H. Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat EndocrMetab Immune Drug Discov. 2012;6(1):30-39.

Stefani M, Bottino G, Fontenelle E, Azulay DR. [Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts].An Bras Dermatol. 2009;84(1):23-29.

Su S, Wong G, Shi W, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24(6):490-502.

Teodorescu MC, Teodorescu M. Tired and sick. Sleep. 2012;35(1):15-16.

Tierra M. Echinacea: an effective alternative to antibiotics. J Herb Pharmacother. 2007;7(2):79-89.

Torres NI, Castilla V, Bruttomesso AC, Eiras J, Galagovsky LR, Wachsman MB. In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1. Antiviral Res. 2012;95(1):37-48.

Toselli F, Matthias A, Gillam EM. Echinacea metabolism and drug interactions: the case for standardization of a complementary medicine. Life Sci. 2009;85(3-4):97-106.

Turner R. (2009) Chapter 53: The Common Cold (pg. 809). In: Mandell G., Bennett J. (Eds.), Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (7th ed.) Churchill Livingstone, An Imprint of Elsevier.

Turner R. (2011) Chapter 369: The Common Cold (pg. 2089). In: Goldman L. (Ed.), Goldman’s Cecil Medicine (24th ed.) Saunders, An Imprint of Elsevier.

Utah Dept. Health. Difference Between Cold and Flu Symptoms. 8/2010. Availabel at: http://health.utah.gov/epi/diseases/flu/ColdvsFlu.pdf Accessed 8/27/2012.\

Valdiani A, Kadir MA, Tan SG, Talei D, Abdullah MP, Nikzad S. Nain-e HavandiAndrographispaniculata present yesterday, absent today: a plenary review on underutilized herb of Iran's pharmaceutical plants. MolBiol Rep. 2012;39(5):5409-5424.

Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents. 2009;34(3):28.

Waarts BL, Aneke OJ, Smit JM, et al. Antiviral Activity of Human Lactoferrin: Inhibition of Alphavirus Interaction with Heparan Sulfate. [In eng] Virology. 2005 Mar 15; 333(2): 284-92.

Walker J. Gilead Sciences Offers Experimental Drug for Coronavirus Treatments, Testing. https://www.wsj.com/articles/gilead-sciences-offers-experimental-drug-for-coronavirus-treatments-testing-11580511519. 2/10/2020.

Walsh NP, Gleeson M, Pyne DB, et al. Position statement. Part two: Maintaining immune health. ExercImmunol Rev. 2011;17:64-103.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, . . . Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell research. 2020:10.1038/s41422-41020-40282-41420.

Wang J, Su B, Ding Z, et al. Cimetidine Enhances Immune Response of Hbv DNA Vaccination Via Impairment of the Regulatory Function of Regulatory T Cells. [In eng] BiochemBiophys Res Commun. 2008 Aug 1; 372(3): 491-6.

Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020.

WHO. World Health Organization. Novel Coronavirus (2019-nCoV). Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed January 29, 2020.

Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold. Planta Med. 2008;74(6):633-637.

Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers GT. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr. 2010;140(3):27.

Worrall G. Common cold. Can Fam Physician. 2011;57(11):1289-1290.

Wrobel JK, Power R, Toborek M. Biological activity of selenium: Revisited. IUBMB Life. 2016;68(2):97-105.

Yang S, Evens AM, Prachand S, et al. Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographispaniculata. Clin Cancer Res. 2010;16(19):4755-4768.

Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004;32(2):132-40.

Zapatera B, Prados A, Gomez-Martinez S, Marcos A. Immunonutrition: methodology and applications. Nutr Hosp. 2015;31 Suppl 3:145-154.

Zhang AL, Story DF, Lin V, Vitetta L, Xue CC. A population survey on the use of 24 common medicinal herbs in Australia. Pharmacoepidemiology and Drug Safety. 2008;17(10):1006-1013

Zhang W, Wang J, Su B, et al. Cimetidine Augments Th1/Th2 Dual Polarized Immune Responses to Recombinant Hbv Antigens. [In eng] Vaccine. 2011 Jun 24; 29(29-30): 4862-8.